11:07 AM EST, 12/27/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were edging 0.03% lower late Friday morning to 1,298.5 on the S&P Europe Select ADR Index, which is up nearly 3% for the week.

From continental Europe, the gainers were led by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company DBV Technologies ( DBVT ) , which climbed 14.7% and 5.4% respectively. They were followed by medical device maker EDAP TMS ( EDAP ) and biopharmaceutical company Cellectis ( CLLS ) , which increased 4.3% and 4% respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biopharmaceutical company Grifols ( GRFS ) , which shed nearly 15% and 5% respectively. They were followed by internet browser company Opera (OPRA) and 3D printer company Materialise (MTLS), which dropped 2.6% and 2.7% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana ( NCNA ) and TC Biopharm ( TCBP ) , which rose 6% and 1.7% respectively. They were followed by medical device maker Smith & Nephew ( SNN ) and oil and gas company Shell (SHEL), which were up 1.4% and 1.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and biotech firm Autolus Therapeutics ( AUTL ) , which fell 7% and 4.1% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and biotech firm Trinity Biotech ( TRIB ) , which were each down 2.6%.